Product Information

POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.1025 per EA under NDC 62037055901. Its NADAC has been published 658 times since Nov 28, 2013.

FDA first approved this application on Jun 2, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 8 MEQ CAPSULE

Potassium Chloride
$0.1025per EA
Discontinued

Strength

600 mg/1

NDC

62037055901

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

6/17/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077419

FDA Approved

6/2/2008

TE Code

AB

On Market Since

8/25/2008

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 658 times since Nov 28, 2013, and over the history we have for it it has declined 82.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1025 per EA
All-time high$0.6513 (Aug 10, 2016)
All-time low$0.1025 (Jun 17, 2026)
52-week high$0.1264
52-week low$0.1025
Median price$0.2866
Average price$0.3157
Largest weekly change+73.8% (Apr 18, 2018)
Weeks tracked658
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

-7.9%

1Y

-15.7%

3Y

-23.5%

5Y

-57.4%

All

-82.9%

Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Actavis Pharma, Inc., is $0.1025 per EA (NDC 62037055901), effective Jul 1, 2026.

How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 82.9%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?

Since Nov 28, 2013, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.1025 (Jun 17, 2026) to a high of $0.6513 (Aug 10, 2016), with a median of $0.2866 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 8 MEQ CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?

POTASSIUM CL ER 8 MEQ CAPSULE (NDC 62037055901) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.